Sezaryen sırasında metilergometrin ve oksitosinin birlikte kullanımının doğum sonrası kanamayı önlemedeki etkisi

Year 2026, Volume: 16 Issue: 1, 13 - 17, 31.01.2026

Necdet Öncü , Ali Buhur

https://doi.org/10.16899/jcm.1786925

Abstract

Özet
Amaç
Doğum sonrası kanama (DSK), dünya çapında maternal morbidite ve mortaliteye katkıda bulunan önemli bir faktördür ve tedavi yöntemi veya bir tedavi yaklaşımının diğerine üstünlüğü konusunda bir fikir birliği yoktur.
Bu çalışma, sezaryen doğumlarında doğum sonrası kanamayı önlemede oksitosin ve metilergonovin kombinasyonunun etkinliğini değerlendirmeyi amaçlamaktadır.
Metodoloji
Bu çalışma, Ocak-Aralık 2022 tarihleri arasında xxxxx Araştırma ve Eğitim Hastanesi'nde 18-35 yaş arası 1292 kadın hasta üzerinde retrospektif olarak yürütülmüştür. Katılımcılar iki gruba ayrılmıştır: biri sadece oksitosin alan grup, diğeri ise oksitosin ve metilergonovin kombinasyonu alan grup.
Birincil sonuçlar, hemoglobin ve hematokrit düzeylerindeki değişikliklerle değerlendirilen doğum sonrası kanamayı (DSK) ve intraoperatif kan kaybını içermektedir. İkincil sonuçlar arasında ek intraoperatif hemostatik uterin sütürlerin kullanımı, cerrahi sürecin uzunluğu, ek uterotoniklere ihtiyaç duyulması ve kan transfüzyonu ihtiyacı yer aldı.
Bulgular: Ek uterotonik ihtiyacında (%27,2 (182), %13,9 (87), p= 0,005), ameliyat öncesi ve sonrası hemoglobin konsantrasyonundaki değişimde 10,81±0,93, 8,23±1,11, p= 0,001 ve hematokrit (11,89±0,93, 10,31±1,20, p= 0,001) değişiminde anlamlı farklılıklar vardı.

Ameliyat süresi, kan transfüzyonu gereksinimleri veya ek hemostatik sütür ihtiyacı açısından gruplar arasında anlamlı bir fark yoktu.
Sonuçlar: Oksitosin ve metilergonovin kombinasyonu, sezaryen geçiren kadınlarda doğum sonrası kanamayı etkili bir şekilde azalttı. Bu grup daha az uterotonik tedaviye ihtiyaç duydu, hemoglobin ve hematokrit seviyelerinde daha küçük düşüşler yaşadı ve sezaryen sırasında daha az kan kaybı yaşadı

Keywords

oksitosin , metilergometrin , postpartum kanama , sezaryen

Ethical Statement

Etik Uygunluk: İnsan katılımcıları içeren tüm prosedürlerde, ilgili araştırma komitesi tarafından belirlenen etik standartlara titizlikle uyulmuş ve 1964 Helsinki Bildirgesi ve değişikliklerine tam olarak uyulmuştur. Etik onay: Çalışma, Helsinki Bildirgesi'nin 2013 tarihli değişikliği uyarınca xxxxxxx Eğitim ve Araştırma Hastanesi etik kurulundan onay almıştır (Onay numarası: 2023.06.84).

Supporting Institution

none

Thanks

YOK

The Effect of the Combined Use of methylergometrine and oxytocin during cesarean section in the prevention of post-partum haemorrhage

Abstract

Abstract
Objective
Postpartum hemorrhage (PPH) is an important contributory factor to maternal morbidity and mortality worldwide, and there is no consensus on treatment method or the superiority of one therapeutic approach over another.
This study aimed to assess the efficacy of oxytocin compared with the combined administration of oxytocin and methylergometrine in preventing postpartum hemorrhage in cesarean sections.
Methodology
This study was conducted retrospectively on 1292 female patients aged 18-35 at the xxxxx Research and Training Hospital from January to December 2022. Participants were categorized into two groups: one receiving oxytocin alone and the other receiving a combination of oxytocin and methylergometrine
The primary outcome measures included postpartum hemorrhage (PPH), assessed by changes in hemoglobin and hematocrit levels, in along with intraoperative blood loss. Secondary outcomes included the use of supplemental intraoperative hemostatic uterine sutures, the length of the surgical process, the need for further uterotonics, and the demand for blood transfusion.
Results
There were significant differences in the need for additional uterotonics 27.2(182) %,13.9% (87) p= 0.005, the change in pre-and postoperative hemoglobin concentration 10.81±0.93, 8.23±1.11, p= 0.001 and hematocrit 11.89±0.93, 10.31±1.20, p= 0.001

There were no significant differences between the groups in terms of operating time, blood transfusion requirements, or need for additional hemostatic sutures.
Conclusions: The combination of oxytocin and methylergometrine effectively reduced postpartum bleeding in women undergoing cesarean sections. This group required less uterotonic treatment, had smaller declines in hemoglobin and hematocrit levels, and experienced less blood loss during cesarean section..

Keywords

oxytocin , methylergonovine , postpartum hemorrhage , cesarean section

Ethical Statement

Ethical Compliance: All procedures involving human participants rigorously adhered to the ethical standards established by the relevant research committee and fully complied with the 1964 Helsinki Declaration and its amendments. Ethical approval: The study received approval from the ethics committee of xxxxxxx Training and Research Hospital in accordance with the 2013 modification of the Declaration of Helsinki (Approval number: 2023.06.84).

Supporting Institution

The authors stated that this study received no financial support.

Thanks

NONE

References

• 1-Buhur A, Oncu N, Erdem D. Analysis of Caesarean Section Rates with the Robson 10 Group Classification. Turk J Health S. 2022;3(2):pp.53-57.
• 2- Ramler PI, Akker T, Henriquez DDCA, et al. Women receiving massive transfusion due to postpartum hemorrhage: A comparison over time between two nationwide cohort studies. Acta Obstet Gynecol Scand. 2019;98:795–804.
• 3-GreeneRA, McKernanJ, ManningE, et al.Major obstetrical haemorrhage: Incidence, managementandqualityofcareinIrishmaternityunits.EurJObstetGynecolReprod Biol.2021;257:114–120.
• 4--Ali Buhur, Dilek Erdem Changing Trends in Cesarean Section Deliveries in a Tertiary Hospital Using the Robson Ten Group Classification J Contemp Med 2023;13(2):301-304.
• 5-Vallera C, Choi LO, Cha CM, Hong RW. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol. Anesthesiol Clin. 2017;35(2):207-219.
• 6- Dyer RA, Van Dyk D, Dresner A. The use of uterotonic drugs during caesarean section. Int J Obstet Anesth 2010;19:313–9.
• 7- Arais F. Pharmacology of oxytocin and prostaglandins. Clin Obstet Gynecol 2000; 43:455–68. 8-Heesen M, Carvalho B, Carvalho JCA, et al. International consensus statement onthe use of uterotonic agents during caesarean section. Anaesthesia. 2019;74:1305–1319.
• 9- Bateman BT, Tsen LC, Liu J, et al. Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011. Anesth Analg 2014;119(6):1344–1349.
• 10- Grassin-Delyle S, Semeraro M, Lamy E, et al. Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomized, crossover trial in healthy volunteers. Br J Anaesth 2022;128: 465–72.
• 11-LeducD, SenikasV, LalondeAB. SocietyofObstetricans andGynaecologistsof Canada. No.235-Activemanagementof the third stage of labour: Prevention and Treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2018;40:e841–e855.
• 12- Bakker R, Pierce S, Myers D. The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach. Arch Gynecol Obstet. 2017;296(2):167-179.
• 13-Şentürk Ş, Kağıtçı M, Balık G, Arslan H, Kır Şahin F. The Effect of the Combined Use of Methylergonovine and Oxytocin during Caesarean Section in the Prevention of Post-partum Haemorrhage. Basic Clin Pharmacol Toxicol. 2016;118(5):338-343.
• 14-Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT. Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents. Am J Obstet Gynecol. 2022;226(3):347-365.
• 15- Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006;70(5):98.
• 16-.Mitchell GG, Elbourne DR. The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor. Online J Curr Clin Trials. 1993;Doc No 83
• 17-Anvaripour A, Shahryari H, Ahmadi S, Ghasemi S, Mirzaei K. Comparison of the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia. Arch Gynecol Obstet. 2013;287(5):979-983.
• 18-Somanathan R, Balu M, Jacob E, Illickal SM. A randomised controlled study for the prevention of post-partum haemorrhage with oxytocin plus methyl ergometrine versus oxytocin alone in the third stage of labour. Int J Reprod Contracept Obstet Gynecol. 2021 ;10(5):1906-13.
• 19-Nuamsiri T, Kaewkiattikun K. Prevention of Postpartum Hemorrhage with Oxytocin versus Ergometrine Plus Oxytocin in the third stage of labor. Thai Journal of Obstetrics and Gynaecology. 2016;97 103.
• 20-Gallos ID, Williams HM, Price MJ, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;4(4):CD011689.
• 21-Aruna Devi, V. "Comparative efficacy of Syntometrine Versus Oxytocin in active management of Third Stage of Labour." PhD diss., Madras Medical College, Chennai, 2010. http://ijcrr.com/uploads/573_pdf.pdf. Last accessed on 18th January, 2021
• 22-Narayana D, Pathak B, Khurana A, Kohli UA. Intramuscular oxytocin 10 units versus intravenous methylergometrine 0.2 mg in active management of the third stage of labour for prevention of postpartum haemorrhage: a comparative study. Int J Reprod Contracept Obstet Gynecol 2020;9:494-498.